Correction: Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents.
- DOI
- 10.1038/s41419-026-08692-3
- Published
- 2026 Jun 2
- Container
- Cell death & disease
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41419-026-08692-3,
title = {Correction: Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents.},
author = {Michaelis M and Rothweiler F and Agha B and Barth S and Voges Y and Löschmann N and von Deimling A and Breitling R and Doerr HW and Rödel F and Speidel D and Cinatl J Jr},
year = {2026},
journal = {Cell death \& disease},
doi = {10.1038/s41419-026-08692-3},
url = {https://doi.org/10.1038/s41419-026-08692-3}
}RIS
TY - JOUR TI - Correction: Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents. AU - Michaelis M AU - Rothweiler F AU - Agha B AU - Barth S AU - Voges Y AU - Löschmann N AU - von Deimling A AU - Breitling R AU - Doerr HW AU - Rödel F AU - Speidel D AU - Cinatl J Jr PY - 2026 JO - Cell death & disease DO - 10.1038/s41419-026-08692-3 UR - https://doi.org/10.1038/s41419-026-08692-3 ER -
APA
M, M., F, R., B, A., S, B., Y, V., N, L., A, V. D., R, B., HW, D., F, R., D, S., & Jr, C. J. (2026). Correction: Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents.. Cell death & disease. https://doi.org/10.1038/s41419-026-08692-3
Source records
- pubmed · retrieved 2026-09-26T03:26:34.892Z